591 research outputs found
Occurrence and Fate of Pharmaceuticals During Bank Filtration – Preliminary Results From Investigations in Germany and the United States
More Exchange at Eye-Level: European Research Cooperation with the People's Republic of China
Diffusive Evolution of Stable and Metastable Phases II: Theory of Non-Equilibrium Behaviour in Colloid-Polymer Mixtures
By analytically solving some simple models of phase-ordering kinetics, we
suggest a mechanism for the onset of non-equilibrium behaviour in
colloid-polymer mixtures. These mixtures can function as models of atomic
systems; their physics therefore impinges on many areas of thermodynamics and
phase-ordering. An exact solution is found for the motion of a single, planar
interface separating a growing phase of uniform high density from a
supersaturated low density phase, whose diffusive depletion drives the
interfacial motion. In addition, an approximate solution is found for the
one-dimensional evolution of two interfaces, separated by a slab of a
metastable phase at intermediate density. The theory predicts a critical
supersaturation of the low-density phase, above which the two interfaces become
unbound and the metastable phase grows ad infinitum. The growth of the stable
phase is suppressed in this regime.Comment: 27 pages, Latex, eps
Human Health Risk Assessment (HHRA) for environmental development and transfer of antibiotic resistanc
This is the final version of the article. Available from NIEHS via the DOI in this record.Open access journalBACKGROUND: Only recently has the environment been clearly implicated in the risk of antibiotic resistance to clinical outcome, but to date there have been few documented approaches to formally assess these risks. OBJECTIVE: We examined possible approaches and sought to identify research needs to enable human health risk assessments (HHRA) that focus on the role of the environment in the failure of antibiotic treatment caused by antibiotic-resistant pathogens. METHODS: The authors participated in a workshop held 4-8 March 2012 in Québec, Canada, to define the scope and objectives of an environmental assessment of antibiotic-resistance risks to human health. We focused on key elements of environmental-resistance-development "hot spots," exposure assessment (unrelated to food), and dose response to characterize risks that may improve antibiotic-resistance management options. DISCUSSION: Various novel aspects to traditional risk assessments were identified to enable an assessment of environmental antibiotic resistance. These include a) accounting for an added selective pressure on the environmental resistome that, over time, allows for development of antibiotic-resistant bacteria (ARB); b) identifying and describing rates of horizontal gene transfer (HGT) in the relevant environmental "hot spot" compartments; and c) modifying traditional dose-response approaches to address doses of ARB for various health outcomes and pathways. CONCLUSIONS: We propose that environmental aspects of antibiotic-resistance development be included in the processes of any HHRA addressing ARB. Because of limited available data, a multicriteria decision analysis approach would be a useful way to undertake an HHRA of environmental antibiotic resistance that informs risk managers.This manuscript was conceived at a workshop (Antimicrobial Resistance in the Environment: Assessing and Managing Effects of Anthropogenic Activities) held 4–8 March 2012 in Montebello, Québec, Canada. The workshop was sponsored by the Canadian Society of Microbiologists, with financial support from AstraZeneca Ltd.; Pfizer Animal Health; F. Hoffman-La Roche Ltd.; GlaxoSmithKline; Unilever; Huvepharma; the American Cleaning Institute; the Canadian Animal Health Institute; the German Federal Ministry for the Environment, Nature Conservation and Nuclear Safety; Health Canada; and the Public Health Agency of Canada
Nest-site competition between bumblebees (Bombidae), social wasps (Vespidae) and cavity-nesting birds in Britain and the Western Palearctic
Capsule: There is no evidence of widespread significant nest-site competition in Britain or the Western Palearctic between cavity-nesting birds and bumblebees or social wasps.
Aims: To investigate competition between cavity-nesting birds and bumblebees and wasps, particularly the range-expanding Tree Bumblebee, Saxon Wasp and European Hornet in Britain, and review evidence throughout the Western Palearctic.
Methods: We compared field data from English and Polish studies of tits and woodpeckers breeding in nest-boxes and/or tree holes to assess nest-site competition with bumblebees and wasps. We reviewed the literature quantifying nest-site competition between birds and these insects in the Western Palearctic.
Results: Bumblebees and wasps are capable of usurping small passerines from nests. In England, these insects commandeered a mean annual 4.1% of tit nests initiated in nest-boxes; occurrence of hornets showed a long-term increase, but not other wasps or bumblebees. Across the Western Palearctic, insect occupation of nest-boxes was generally low, and was lower in England than in Poland. No insects were discovered in tree cavities, including those created by woodpeckers (Picidae).
Conclusion: Nest-site competition between cavity-nesting birds and bumblebees and wasps appears to be a ‘nest-box phenomenon’, which may occasionally interfere with nest-box studies, but appears negligible in natural nest-sites
Household Disposal of Pharmaceuticals as a Pathway for Aquatic Contamination in the United Kingdom
Pharmaceuticals are produced and used in increasingly large volumes every year. With this growth comes concern about the fate and effects of these compounds in the environment. The discovery of pharmaceuticals in the aquatic environment has stimulated research in the last decade. A wide range of pharmaceuticals has been found in fresh and marine waters, and it has recently been shown that even in small quantities, some of these compounds have the potential to cause harm to aquatic life. The primary pathway into the environment is the use and disposal of medicines; although much of the research in the area currently focuses on the removal of pharmaceuticals during sewage treatment processes, disposal via household waste might be a significant pathway requiring further research. To investigate the household disposal of unused and expired pharmaceuticals as a source of pharmaceutical compounds in the environment, we carried out a survey and interviewed members of 400 households, predominantly from southeastern England. We used the information on when and how they disposed of unfinished pharmaceuticals to construct a conceptual model to assess the pathways of human pharmaceuticals into the environment. The model demonstrated that disposal of unused pharmaceuticals, either by household waste or via the sink or toilet, may be a prominent route that requires greater attention
Mapping of wetland and riparian habitat for the National Wetlands Inventory: Gallatin Valley, Montana
NY-ESO-1 tumour associated antigen is a cytoplasmic protein detectable by specific monoclonal antibodies in cell lines and clinical specimens
NY-ESO-1 gene encodes a novel member of the cancer/testis (CT) family of human tumour-associated antigens (TAA). Specific monoclonal antibodies (mAb) have identified the corresponding gene product in lysates of tumour cell lines as a 22 kDa protein but no data are available concerning its intracellular location or distribution within neoplastic tissues. We have generated NY-ESO-1 specific mAbs recognizing the target molecule in cytospin preparations and in sections from clinical tumour specimens. These reagents identify NY-ESO-1 TAA in melanoma cell lines expressing the specific gene as a cytoplasmic protein, sharing the intracellular location of most MAGE TAA. In a series of 12 melanoma specimens, specific staining, limited to neoplastic cells, was detectable in the five cases where NY-ESO-1 gene expression was observed. In two of them over 90% of tumour cells showed evidence of positive staining. Lower percentages of positive neoplastic cells ranging between single cells and 50% were observed in the remaining tumours. These data suggest that active specific immunotherapies targeting NY-ESO-1, alone or in combination with other TAA could be of high clinical relevance in sizeable subgroups of melanoma patients. © 2000 Cancer Research Campaig
Electronic monitoring for improved accountability in western Pacific tuna longline fisheries
The collection of accurate fisheries catch data is critical to ensuring sustainable management of tuna fisheries, mitigating their environmental impacts and for managing transboundary fish stocks. These challenges are exemplified by the western Pacific tuna longline fishery, who's management includes >26 nations, but is informed by critically low coverage of fishing activities by scientific observers. The gap in observer data could be filled by electronic monitoring (EM), but there are few trials that span multiple nations. A large-scale trial of EM systems on tuna longliners based in Palau, Federated States of Micronesia and the Republic of the Marshall Islands, is reported on. Comparisons are made of catch rates of market and bycatch species in corresponding EM, logbook and human observer data. Retained species were under-reported in logbooks by up to three times and discards of many species were not reported in logbooks. Discards identified in the EM data included threatened species such as marine turtles. Catch rate estimates from EM data were comparable to those estimated by human observers. EM data recorded a higher species diversity of catches than logbook data. Analysis of the EM data indicated clusters of bycatch that were associated with specific fishing practices. These results suggest further expansion of EM could inform improved management of both target and bycatch species. Ultimately greater coverage of EM data could contribute to reconciling debates in international stock allocation schemes and support actions to reduce the impacts of the fishery on threatened bycatch species
- …
